Natural chondroitin sulfate (CS), extracted from animal cartilage, is widely used in the pharmaceuticals and foods. However, contamination with animal-derived heteropolysaccharides presents significant challenges, including potential immune responses. To address this, we developed a green and efficient method for synthesizing chondroitin sulfate E (CSE) via enzymatic synthesis, identifying Ec CHST15, a sulfotransferase that catalyzes the conversion of chondroitin sulfate A (CSA) to CSE. We investigated the novel catalytic mechanism of CHST15 through quantum mechanical (QM) calculations and experimental validation, confirming its alignment with the SN2 reaction mechanism. Subsequently, we enhanced the catalytic efficiency of CHST15 using protein engineering, improving the catalytic efficiency from 18.1% in the wild type (WT) to 62.5% in the M7 mutant—a 3.5-fold increase. Finally, we constructed a six-enzyme cascade whole-cell catalyst, achieving a 72.2% conversion of 15 g/L CSA to produce CSE within 24 h. These findings offer a promising strategy for the industrial production of CSE. IMPORTANCE: Current methods for obtaining chondroitin sulfate (CS) primarily rely on tissue extraction and chemical synthesis. However, these approaches are hindered by contamination risks from animal-derived heteropolysaccharides and the technical challenges inherent in complex chemical synthesis, limiting the scalability of industrial CS production. To address this, we developed a green and efficient enzymatic biosynthesis method for chondroitin sulfate E (CSE). By identifying and engineering the sulfotransferase CHST15 from Erpetoichthys calabaricus , we created a mutant ( Ec CHST15 M7 ) with a 3.5-fold increase in catalytic efficiency toward chondroitin sulfate A (CSA) compared to the wild-type enzyme. Additionally, we constructed a six-enzyme cascade whole-cell biocatalyst, achieving a 72.2% conversion rate from CSA to CSE. This study opens new avenues for the industrial-scale production of CSE through sustainable enzymatic processes.
Ficus pandurata Hance (Moraceae) is widely used in traditional Chinese medicine for treatment of various diseases and also has high ornamental value (Khedr et al. 2016). In September 2018, distinct blight symptoms were observed on leaves of F. pandurata at a flower gardening factory in Suyang, Jiangsu, China. Approximately, 23% of F. pandurata plants (a total of about 1000 plants) were showed disease symptoms and had reduced ornamental value of the leaves. Initial leaf symptoms were characterized by yellow to brown, irregular-shaped lesions. The lesions later expanded to the entire leaf. Infected leaves turned dark brown and withered. A portion of the symptomatic leaf tissues were surface sterilized in 75% ethanol for 10s, and then in 1% sodium hypochlorite for 3 min, rinsed three times in sterile distilled water, plated onto potato dextrose agar (PDA), and incubated at 25°C in the dark. The obtained fungal colonies were initially white, becoming gray to black, wool-like, and growing slowly. Conidia were ...